Clinical Trial Update: Early Prophylactic Donor Lymphocyte Infusion After Allo-HSCT for Patients With AML [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study of early prophylactic donor lymphocyte infusion after allogeneic stem cell transplantation in patients with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Donor Lymphocyte Infusion

Snippet

Sponsor: Institut Paoli-Calmettes | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: ACTIVE_NOT_RECRUITING